title: Proteoglycans of Wharton's jelly.
abstract: Wharton's jelly (WJ) is a myxomatous substance surrounding the blood vessels of the umbilical cord. Proteoglycans (PGs) of Wharton's jelly have not been studied to date therefore it was decided to explore proteoglycan composition of this tissue. Proteoglycans were subjected to dissociative extraction with 4M guanidine hydrochloride containing Triton X-100 and protease inhibitors, purified by Q-Sepharose anion-exchange chromatography and lyophilised. They were analysed by gel filtration and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) before and after treatment with chondroitinase ABC. It was found that 1g of Wharton's jelly contains 2.43+/-0.63mg (n=10) of sulphated glycosaminoglycans (GAGs), reflecting the presence of proteoglycans. The proteoglycans were mainly substituted with chondroitin/dermatan sulphate (DS) chains. The predominant proteoglycan fraction included small proteoglycans with core proteins of 45 and 47kD, immunologically related to decorin (45 and 47kD) and biglycan (45kD). The expression of decorin core proteins was much higher than that of biglycan. Larger proteoglycans (core proteins of 90, 110, 220 and 260kD) were found in lower amounts. The most abundant of them (core protein of 260kD) was immunologically related to versican. Perlecan was not identified in Wharton's jelly. The study shows that Wharton's jelly contains mainly small chondroitin/dermatan sulphate proteoglycans, with decorin strongly predominating over biglycan. We suggest that an intensive expression of decorin is associated with very high content of its ligand, collagen.
authors.affiliation: Department of Medical Biochemistry, Medical Academy of Biatystok, 15-089 Biatystok, Poland. tgogiel@amb.ac.bialystok.pl
authors.forename: Tomasz
authors.initials: T
authors.lastname: Gogiel
authors.forename: Edward
authors.initials: E
authors.lastname: Bańkowski
authors.forename: Stefan
authors.initials: S
authors.lastname: Jaworski
mesh_terms: D000328:Adult; D058578:Biglycan; D015153:Blotting, Western; D019765:Chondroitin ABC Lyase / Q000378:metabolism; D011508:Chondroitin Sulfate Proteoglycans / Q000032:analysis / Q000276:immunology; D002809:Chondroitin Sulfates / Q000032:analysis; D058575:Decorin; D003871:Dermatan Sulfate / Q000032:analysis; D004591:Electrophoresis, Polyacrylamide Gel; D016326:Extracellular Matrix Proteins; D005260:Female; D006025:Glycosaminoglycans / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D019812:Heparan Sulfate Proteoglycans / Q000032:analysis / Q000276:immunology; D006801:Humans; D007231:Infant, Newborn; D037181:Lectins, C-Type; D011509:Proteoglycans / Q000032:analysis* / Q000276:immunology / Q000378:metabolism; D014470:Umbilical Cord / Q000737:chemistry*; D053675:Versicans
chemical_list: C546884:BGN protein, human; D058578:Biglycan; D011508:Chondroitin Sulfate Proteoglycans; C546878:DCN protein, human; D058575:Decorin; D016326:Extracellular Matrix Proteins; D006025:Glycosaminoglycans; D019812:Heparan Sulfate Proteoglycans; D037181:Lectins, C-Type; D011509:Proteoglycans; C508322:VCAN protein, human; D053675:Versicans; C071927:perlecan; D003871:Dermatan Sulfate; D002809:Chondroitin Sulfates; D019765:Chondroitin ABC Lyase